Design and Characterization of Floating Tablets of Ranolazine - Manivannan, Rangasamy;Krishnarajan, Devarajan;Shankar, Mani
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

Ranolazine is used for the treatment of Angina pectoris, which has a short half-life of 1.4-1.9 hours. Ranolazine floating tablets were prepared by direct compression technique using polymers such as HPMC, Carbopol 934P and Chitosan. Tablets were evaluated for its physical properties, viz. hardness, friability, weight variation, In vitro Buoyancy, swelling studies, In vitro drug release and In-vivo gastric Residence time. Drug release kinetics was studied for zero order, first order, Higuchi and Korsmeyer-Peppas. Finally, it can be concluded that promising controlled release by gastro…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Ranolazine is used for the treatment of Angina pectoris, which has a short half-life of 1.4-1.9 hours. Ranolazine floating tablets were prepared by direct compression technique using polymers such as HPMC, Carbopol 934P and Chitosan. Tablets were evaluated for its physical properties, viz. hardness, friability, weight variation, In vitro Buoyancy, swelling studies, In vitro drug release and In-vivo gastric Residence time. Drug release kinetics was studied for zero order, first order, Higuchi and Korsmeyer-Peppas. Finally, it can be concluded that promising controlled release by gastro retentive floating tablets of Ranolazine was developed using a combination of HPMC K15M and Chitosan.
Autorenporträt
Dr.R.Manivannan, M.Pharm., Ph.D working as a Professor, Department of Pharmaceutics, JKKMMRF-Annai JKK Sampooraniammal College of Pharmacy, Tamilnadu, India. He is a author of several journal published in reputed journals and is a life member of APTI, IPGA, INPHARM and IPA.